KBC Group
PRCT icon

KBC Group’s Procept Biorobotics PRCT Stock Holding History

KBC Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$31K Hold
1,713
– – ﹤0.01% 1803
2026
Q2 		$39K Hold
1,713
– – ﹤0.01% 1781
2026
Q1 		$43K Hold
1,713
– – ﹤0.01% 1708
2025
Q4 		$54K Hold
1,713
– – ﹤0.01% 1615
2025
Q3 		$61K Hold
1,713
– – ﹤0.01% 1567
2025
Q2 		$99K Sell
1,713
-523
-23% -$29.6K ﹤0.01% 1211
2025
Q1 		$130K Hold
2,236
– – ﹤0.01% 1334
2024
Q4 		$180K Buy
2,236
+705
+46% +$60.2K ﹤0.01% 1190
2024
Q3 		$123K Buy
1,531
+376
+33% +$26.7K ﹤0.01% 1156
2024
Q2 		$71K Hold
1,155
– – ﹤0.01% 1405
2024
Q1 		$57K Buy
+1,155
New +$55K ﹤0.01% 1473

Other funds holding PRCT

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Bastion Asset Management
Bastion Asset Management Montreal, Canada $229M AUM 5.92% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

KBC Group's PRCT Position: Q3 2026 in Review

KBC Group held its Procept Biorobotics (PRCT) position steady in Q3 2026 at 1,713 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

KBC Group first reported a position in PRCT in Q1 2024 and has held it in 11 quarters since. The position peaked at $180K in Q4 2024. 95 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • KBC Group held 1,713 shares of Procept Biorobotics worth $31K as of Q3 2026.
  • KBC Group left its Procept Biorobotics share count unchanged in Q3 2026.
  • Procept Biorobotics made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1803 holding.
  • KBC Group first reported a position in Procept Biorobotics in Q1 2024 and has held it in 11 quarters since.
  • KBC Group's Procept Biorobotics position peaked at $180K in Q4 2024.
  • 95 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.